ERBB2 and cancer: Even though ST6GAL1 transcript abundance was diminished overall in breast cancer patients compared to matched controls (Fig. 1A), TNBC aggressive cancers have elevated ST6GAL1 mRNA compared to HER2+ and ER+ subtypes (Fig. 1B).